...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma.
【24h】

Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma.

机译:鼻咽癌螺旋断层放射疗法与步调强度调制放射疗法的剂量学比较。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The study evaluates and quantifies the potential dosimetric gains of helical tomotherapy (HT) versus step-and-shoot intensity-modulated radiotherapy (SaS-IMRT) for nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: Twenty consecutive NPC patients curatively treated by HT were examined. Each case was planned by HT and SaS-IMRT (ADAC Pinnacle(3)) planning system, respectively. Dose plans were compared using dose volume histograms (DVH), conformity index (CI), homogeneity index (HI), and minimal dose to 1cc (D(min_1cc)) of the planned target volume (PTV) and a comprehensive quality index (CQI) of ten organs at risk (OARs). The prescribed dose/fractionation was 72Gy to the PTV, 64.8Gy to the elective PTV, and 54Gy to the clinically negative neck region. The plan of 54Gy to the PTV (PTV(54)) was used to evaluate the CI and HI in the target. The cumulative doses of the three PTV plans to the OARs were calculated. RESULTS: We observed the HT plans significantly improved the CI (improvement ratio:11.9+/-5.5%) and HI (improvement ratio: 8.8+/-1.5%) of the PTV(54) compared with SaS-IMRT plans. In addition, the mean/maximal dose of most of the OARs except chiasm was significantly reduced in HT plans, with the CQI of 0.92+/-0.08. A negative result of HT in chiasm was observed but only significantly revealed in cases without skull base infiltration. CONCLUSIONS: A dosimetric gain in CI and HI of PTV and sparing of OARs was significantly obtained in HT versus SaS-IMRT plans in NPC patients. Whether such dosimetric superiority in HT could transfer into clinical advantages needs further investigation.
机译:目的:该研究评估并定量了螺旋断层扫描(HT)与步调强度调制放射治疗(SaS-IMRT)鼻咽癌(NPC)的潜在剂量学收益。材料与方法:对20例连续接受HT治疗的NPC患者进行了检查。每个案例分别由HT和SaS-IMRT(ADAC Pinnacle(3))计划系统计划。使用剂量体积直方图(DVH),合格指数(CI),均匀性指数(HI)和计划目标体积(PTV)的1cc(D(min_1cc))最小剂量和综合质量指数(CQI)比较剂量计划)的十个高危器官(OAR)。规定的剂量/剂量对PTV为72Gy,选择性PTV为64.8Gy,临床颈部阴性区域为54Gy。 PTV的54Gy计划(PTV(54))用于评估目标中的CI和HI。计算了三个PTV计划对OAR的累计剂量。结果:我们观察到,与SaS-IMRT计划相比,HT计划显着提高了PTV(54)的CI(改善率:11.9 +/- 5.5%)和HI(改善率:8.8 +/- 1.5%)。此外,在HT计划中,除chiasm以外的大多数OAR的平均/最大剂量均显着降低,CQI为0.92 +/- 0.08。观察到HT在黑斑病中呈阴性结果,但仅在没有颅底浸润的情况下才明显发现。结论:HT与SaS-IMRT计划相比,NPC患者的PTV CI和HI剂量增加以及OAR节省很少。 HT的这种剂量优势是否可以转化为临床优势还需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号